MedPath

SALLY FALK

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)β€’ Click on a phase to view related trials

Not Applicable
3 (100.0%)

Oxygen Enhanced MRI Measurement in Head and Neck Cancer: Validation and Efficacy of Response.

Not Applicable
Conditions
Head and Neck Cancer
First Posted Date
2018-08-24
Last Posted Date
2018-08-24
Lead Sponsor
Sally Falk
Target Recruit Count
40
Registration Number
NCT03646747

Simultaneous CBCT Acquisition During Arc Radiotherapy

Not Applicable
Conditions
Prostate Cancer
Lung Cancer
First Posted Date
2014-04-28
Last Posted Date
2015-02-09
Lead Sponsor
Sally Falk
Target Recruit Count
75
Registration Number
NCT02123888
Locations
πŸ‡¬πŸ‡§

The Christie NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom

Visual Feedback With Optical Sensing - A Feasibility Study

Not Applicable
Completed
Conditions
Lung Cancer
First Posted Date
2014-02-21
Last Posted Date
2018-02-23
Lead Sponsor
Sally Falk
Target Recruit Count
16
Registration Number
NCT02068378
Locations
πŸ‡¬πŸ‡§

The Christie NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.